• Drugs and the FDA

  • Safety, Efficacy, and the Public's Trust
  • De: Mikkael A. Sekeres
  • Narrado por: Mike Lenz
  • Duração: 8 horas e 40 minutos

Assine e ganhe 30% de desconto neste título

R$ 19,90 /mês

R$ 19,90/mês após o teste gratuito de 30 dias. Cancele a qualquer momento.
Curta mais de 100.000 títulos de forma ilimitada.
Ouça quando e onde quiser, mesmo sem conexão
Sem compromisso. Cancele grátis a qualquer momento.
Drugs and the FDA  Por  capa

Drugs and the FDA

De: Mikkael A. Sekeres
Narrado por: Mike Lenz
Teste grátis por 30 dias

R$ 19,90/mês após o teste gratuito de 30 dias. Cancele a qualquer momento.

Compre agora por R$ 53,99

Compre agora por R$ 53,99

Pagar usando o cartão terminado em
Ao confirmar sua compra, você concorda com as Condições de Uso da Audible e a Política de Privacidade da Amazon. Impostos, quando aplicável. PRECISA SER AJUSTADO

Sinopse

Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate United States authority on a drug's safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and former chair of the FDA's cancer drug advisory committee—tells the story of how the FDA became the most trusted regulatory agency in the world. It took a series of tragedies and health crises, as well as patient advocacy, for the government to take responsibility for ensuring the efficacy and safety of drugs and medical devices.

Before the FDA existed, drug makers could hawk any potion, claim treatment of any ailment, and make any promise on a label. But then, throughout the twentieth century, the government was forced to take action when children were poisoned by contaminated diphtheria and smallpox vaccines, an early antibiotic contained antifreeze, a drug prescribed for morning sickness in pregnancy caused babies to be born disfigured, and access to AIDS drugs was limited to a few clinical trials while thousands died. Sekeres describes all these events against the backdrop of the contentious 2011 hearings on the breast cancer drug Avastin, in which he participated as a panel member.

©2022 Mikkael A. Sekeres (P)2023 Tantor

Mais do mesmo

O que os ouvintes dizem sobre Drugs and the FDA

Nota média dos ouvintes. Apenas ouvintes que tiverem escutado o título podem escrever avaliações.

Avaliações - Selecione as abas abaixo para mudar a fonte das avaliações.